Suppr超能文献

行房颤消融术患者中中断或不中断口服抗凝治疗。

Interrupted or Uninterrupted Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation.

机构信息

Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, No. 1, Minde Road, Donghu District, Nanchang, 330006, Jiangxi, People's Republic of China.

Department of Radiology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, People's Republic of China.

出版信息

Cardiovasc Drugs Ther. 2020 Jun;34(3):371-381. doi: 10.1007/s10557-020-06967-1.

Abstract

BACKGROUND AND PURPOSE

The safety and efficacy of uninterrupted, minimally interrupted (one dose skipped) or completely interrupted (24 h skipped) oral anticoagulant therapy in patients with atrial fibrillation (AF) ablation are poorly defined. We conducted a network meta-analysis to explore the effect of interrupted or uninterrupted oral anticoagulants in patients with AF undergoing ablation.

METHODS

The Cochrane Library, PubMed and Embase databases were systematically searched for studies comparing uninterrupted, minimally interrupted or completely interrupted non-vitamin K antagonist oral anticoagulants (NOACs) with continuous or interrupted warfarin in patients undergoing AF ablation.

RESULTS

Twelve randomized clinical trials (RCTs) with a total of 5597 patients with AF undergoing catheter ablation were included. For thromboembolism, minimally interrupted NOACs (OR 0.03, 95% CI 0.01-0.35), uninterrupted NOACs (OR 0.04, 95% CI 0.01-0.23) and continuous VKAs (OR 0.05, 95% CI 0.01-0.21) were better than interrupted warfarin. The risk of total bleeding appeared higher in the completely interrupted NOAC group compared with the minimally interrupted NOACs (OR 2.74, 95% CI 1.18-6.37), uninterrupted NOACs (OR 2.15, 95% CI 1.05-4.38) and uninterrupted warfarin (OR 2.04, 95% CI 1.02-4.08). To reduce the risk of total bleeding, minimally interrupted NOACs (OR 0.15, 95% CI 0.08-0.27), uninterrupted NOACs (OR 0.19, 95% CI 0.14-0.42) and uninterrupted warfarin (OR 0.24, 95% CI 0.15-0.39) were better than interrupted warfarin. In the event of major bleeding, there was no significant difference in the interrupted NOAC, uninterrupted NOAC, interrupted VKA and uninterrupted VKA groups.

CONCLUSIONS

These three NOAC strategies may have similar safety and efficacy in terms of thromboembolism and major bleeding complications. The total bleeding risk of completely interrupted oral anticoagulants is higher than that of uninterrupted and minimally interrupted NOACs. For thromboembolism, minimally interrupted NOACs, uninterrupted NOACs and continuous VKAs were better than interrupted warfarin.

摘要

背景与目的

在房颤(AF)消融患者中,未中断、最小程度中断(漏服一剂)或完全中断(漏服 24 小时)口服抗凝治疗的安全性和有效性尚未明确。我们进行了一项网状荟萃分析,以探讨中断或未中断口服抗凝剂在接受 AF 消融的患者中的作用。

方法

系统检索 Cochrane 图书馆、PubMed 和 Embase 数据库,以比较房颤消融患者中未中断、最小程度中断或完全中断的非维生素 K 拮抗剂口服抗凝剂(NOACs)与连续或中断华法林的研究。

结果

纳入了 12 项随机临床试验(RCTs),共计 5597 例接受导管消融的 AF 患者。对于血栓栓塞,最小程度中断的 NOACs(OR 0.03,95%CI 0.01-0.35)、未中断的 NOACs(OR 0.04,95%CI 0.01-0.23)和连续 VKAs(OR 0.05,95%CI 0.01-0.21)优于中断的华法林。与最小程度中断的 NOACs 相比,完全中断的 NOACs 组总出血风险更高(OR 2.74,95%CI 1.18-6.37)、未中断的 NOACs(OR 2.15,95%CI 1.05-4.38)和未中断的华法林(OR 2.04,95%CI 1.02-4.08)。为降低总出血风险,最小程度中断的 NOACs(OR 0.15,95%CI 0.08-0.27)、未中断的 NOACs(OR 0.19,95%CI 0.14-0.42)和未中断的华法林(OR 0.24,95%CI 0.15-0.39)优于中断的华法林。在发生大出血的情况下,中断的 NOAC、未中断的 NOAC、中断的 VKA 和未中断的 VKA 组之间没有显著差异。

结论

这三种 NOAC 策略在血栓栓塞和大出血并发症方面可能具有相似的安全性和疗效。完全中断口服抗凝剂的总出血风险高于未中断和最小程度中断的 NOACs。对于血栓栓塞,最小程度中断的 NOACs、未中断的 NOACs 和连续 VKAs 优于中断的华法林。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验